References
- World Health Organization. Tobacco use declines despite tobacco industry efforts to jeopardize progress [displayed 28 August 2024]. Available at
https://www.who.int/news/item/16-01-2024-tobacco-use-declines-despite-tobacco-industry-efforts-to-jeopardize-progress - World Health Organization. WHO report on the global tobacco epidemic, 2023: protect people from tobacco smoke. Geneva: WHO; 2023.
- U.S. Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General – Executive Summary. Atlanta (GA): Centers for Disease Control and Prevention (US); 2006. PMID: 20669524
- Leonardi-Bee J, Britton J, Venn A. Secondhand smoke and adverse fetal outcomes in nonsmoking pregnant women: a meta-analysis. Pediatrics 2011;127:734–41. doi: 10.1542/peds.2010-3041
- Sasco AJ, Secretan MB, Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 2004;45(Suppl 2):S3–9. doi: 10.1016/j.lungcan.2004.07.998
- Khoramdad M, Vahedian-azimi A, Karimi L, Rahimi-Bashar F, Amini H, Sahebkar A. Association between passive smoking and cardiovascular disease: A systematic review and meta-analysis. IUBMB Life 2020;72:677–86. doi: 10.1002/iub.2207
- Oono IP, MacKay DF, Pell JP. Meta-analysis of the association between secondhand smoke exposure and stroke. J Public Health 2011;33:496–502. doi: 10.1093/pubmed/fdr025
- Zhu AZX, Tyndale RF. Nicotine metabolism and its implications. In: Anzenbacher P, Ulrich MZ, editors. Metabolism of drugs and other xenobiotics. Weinheim: Wiley-VCH Verlag GmbH & Co. KgaA; 2012. p. 465–92. doi: 10.1002/9783527630905
- Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol 2009;49:57–71. doi: 10.1146/annurev.pharmtox.48.113006.094742
- Brčić Karačonji I. Facts about nicotine toxicity. Arh Hig Rada Toksikol 2005;56:363–71. PMID: 16370520
- Haufroid V, Lison D. Urinary cotinine as a tobacco-smoke exposure index: a minireview. Int Arch Occup Environ Health 1998;71:162–8. doi: 10.1007/s004200050266
- Marques H, Cruz-Vicente P, Rosado T, Barroso M, Passarinha LA, Gallardo E. Recent developments in the determination of biomarkers of tobacco smoke exposure in biological specimens: a review. Int J Environ Res Public Health 2021;18(4):1768. doi: 10.3390/ijerph18041768
- Yuan JM, Butler LM, Stepanov I, Hecht SS. Urinary tobacco smoke-constituent biomarkers for assessing risk of lung cancer. Cancer Res 2014;74:401–11. doi: 10.1158/0008-5472.CAN-13-3178
- Nebot M, López MJ, Gorini G, Neuberger M, Axelsson S, Pilali M, Fonseca C, Abdennbi K, Hackshaw A, Moshammer H, Laurent AM, Salles J, Georgouli M, Fondelli MC, Serrahima E, Centrich F, Hammond SK. Environmental tobacco smoke exposure in public places of European cities. Tob Control 2005;14:60–3. doi: 10.1136/tc.2004.008581
- Dempsey D, Tutka P, Jacob P 3rd, Allen F, Schoedel K, Tyndale RF, Benowitz NL. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther 2004;76:64–72. doi: 10.1016/j.clpt.2004.02.011
- Veršić Bratinčević M, Visković T, Sutlović D. Comparison of the solid phase and liquid-liquid extraction methods for methadone determination in human serum and whole blood samples using gas chromatography/mass spectrometry. Arh Hig Rada Toksikol 2017;68:308–14. doi: 10.1515/aiht-2017-68-2953
- Jones MR, Wipfli H, Shahrir S, Avila-Tang E, Samet JM, Breysse PN, Navas-Acien A; FAMRI Bar Study Investigators. Secondhand tobacco smoke: an occupational hazard for smoking and non-smoking bar and nightclub employees. Tob Control 2013;22:308–14. doi: 10.1136/tobaccocontrol-2011-050203
- Lawrence JS, Kennedy K, Balaras C, Persily A, Weekes LCN. ASHRAE Position document on environmental tobacco smoke. ASHRAE, Peachtree Corners (GA): 2020 [displayed 26 July 2024]. Available at
https://www.ashrae.org/file%20library/about/position%20documents/pd_environmental-tobacco-smoke-2023-06-28.pdf